Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Pak Fah Yeow International's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pak Fah Yeow International Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Pak Fah Yeow International's Days Payable distribution charts can be found below:
* The bar in red indicates where Pak Fah Yeow International's Days Payable falls into.
Pak Fah Yeow International Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pak Fah Yeow International (HKSE:00239) has a Days Payable of 25.85 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Pak Fah Yeow International and its competitors. This is near median its historical median of 24.26. Over the past decade, Pak Fah Yeow International's Days Payable has ranged from 10.82 to 262.92. According to the industry distribution chart, Pak Fah Yeow International ranks #845 out of 927 companies in the Drug Manufacturers industry, placing it in the top 91.2%.
Is Pak Fah Yeow International's Days Payable too high?
Pak Fah Yeow International's current Days Payable of 25.85 is near median its 10-year median of 24.26. Over the past 10 years, this metric has ranged from a low of 10.82 to a high of 262.92. The Drug Manufacturers industry median Days Payable is 90.16. Pak Fah Yeow International's value of 25.85 is 71.3% below this industry median. Based on the distribution chart, Pak Fah Yeow International ranks #845 out of 927 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Pak Fah Yeow International has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pak Fah Yeow International's Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Pak Fah Yeow International ranks #845 out of 927 companies for Days Payable. This places Pak Fah Yeow International in the lower half of its industry. The industry median Days Payable is 90.16. Pak Fah Yeow International's value of 25.85 is 71.3% below this benchmark. Historically, Pak Fah Yeow International's own Days Payable has ranged from 10.82 to 262.92 over the past decade. While the company's 10-year median is 24.26 vs. the industry median of 90.16, Pak Fah Yeow International has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.16, based on 927 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pak Fah Yeow International's current Days Payable of 25.85 is 71.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Pak Fah Yeow International and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pak Fah Yeow International's current Days Payable is 25.85, which is near median its own 10-year median of 24.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pak Fah Yeow International stock overvalued right now?
Based on GuruFocus' analysis, Pak Fah Yeow International (HKSE:00239) is currently considered Fairly Valued. The stock's GF Value™ is HK$2.17, compared to a current price of HK$2.32 — trading 6.7% above its estimated fair value. The current Days Payable is 25.85, which is near median its 10-year median of 24.26 and 71.3% below the Drug Manufacturers industry median of 90.16. Pak Fah Yeow International's overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Pak Fah Yeow International (HKSE:00239), the current Days Payable is 25.85 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pak Fah Yeow International (HKSE:00239) Overvalued in 2026?
Based on GuruFocus' analysis, Pak Fah Yeow International stock appears to be overvalued.
The current stock price of HK$2.32 is trading 6.7% above its estimated GF Value™ of HK$2.17.
GuruFocus considers Pak Fah Yeow International to be Fairly Valued.
Key valuation signals for HKSE:00239:
Days Payable: 25.85 (near median its 10-year median of 24.26)
GF Value™: HK$2.17 vs. price of HK$2.32 (6.7% above fair value)
Industry Position: 71.3% below the Drug Manufacturers median (#845 of 927)
No single metric tells the full story. See the HKSE:00239 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pak Fah Yeow International Ltd, with its subsidiaries, is engaged in the manufacture and distribution of healthcare products, including Hoe Hin branded products. It also engages in real estate investment and treasury investment businesses. It has three business segments, namely healthcare, property investments, and treasury investments. The Company derives the majority of its revenues from the Healthcare segment.The Groups businesses cover Hong Kong, Macau, other regions in the Peoples Republic of China (the PRC or Chinese Mainland), Southeast Asia, North America and the United Kingdom.
80GF Score
Get the complete analysis for HKSE:00239
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00239 has been successfully added to your 
